US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Shuttle Pharmaceuticals Inc

0.3100

+0.01344.52%

Post-market: 0.31000.00000.00%19:46 EDT

Volume:404.78K

Turnover:122.40K

Market Cap:1.94M

PE:-0.09

High:0.3167

Open:0.3002

Low:0.2880

Close:0.2966

Loading ...

Overview Company News Filings

Shuttle first patient enrollment, dosing in Phase 2 Ropidoxuridine line

BRIEF-Shuttle Pharma Expands Patient Enrollment For Phase 2 Clinical Trial

Shuttle Pharma Expands Patient Enrollment for Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients With Glioblastoma as Uva Cancer Center Doses Its First Patient

THOMSON REUTERS

Shuttle Pharma Expands Patient Enrollment for Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma as UVA Cancer Center Doses Its First Patient

Shuttle Pharmaceuticals Q3 EPS $(1.59) Down From $(0.91) YoY

Shuttle Pharma Provides Third Quarter 2024 Corporate Update

THOMSON REUTERS

Shuttle Pharma Provides Third Quarter 2024 Corporate Update

Shuttle Pharmaceuticals Prices $4.5 Million Public Offering

MT Newswires Live

Shuttle Pharmaceuticals dips 6%, prices $4.5M share offering

BRIEF-Shuttle Pharmaceuticals Holdings Announces Pricing Of $4.5 Mln Public Offering

Shuttle Pharmaceuticals prices $4.5M at-the-market offering at $1.525 per share

Shuttle Pharmaceuticals Holdings, Inc. Announces Pricing of $4.5 Million Public Offering Priced at-the-Market Under Nasdaq Rules

THOMSON REUTERS

Shuttle Pharmaceuticals Holdings Inc - Prices Public Offering of up to 2.9 Mln Shares of Common Stock and Warrants at$1.525 per Share

THOMSON REUTERS

Shuttle Pharmaceuticals Holdings, Inc. Announces Pricing of $4.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules

Shuttle Pharma Pays off Senior Secured Convertible Note

THOMSON REUTERS

Shuttle Pharma Pays Off Senior Secured Convertible Note

US Stocks Mixed; McDonald's Posts Upbeat Earnings

Shuttle Pharmaceuticals doses first patients in Phase 2 trial of Ropidoxuridine

Shuttle Pharma Doses First Patients in Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients With Glioblastoma

THOMSON REUTERS

Shuttle Pharmaceuticals Soars Premarket Following Completion of Phase 2 Glioblastoma Trial Site Enrollment

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/SHPH/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SHPH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SHPH\",,,,,undefined,":{"symbol":"SHPH","market":"US","secType":"STK","nameCN":"Shuttle Pharmaceuticals Inc","latestPrice":0.31,"timestamp":1745611200000,"preClose":0.2966,"halted":0,"volume":404784,"hourTrading":{"tag":"盘后","latestPrice":0.31,"preClose":0.31,"latestTime":"19:46 EDT","volume":26404,"amount":7950.7017,"timestamp":1745624777585},"delay":0,"floatShares":5554536,"shares":6257693,"eps":-3.304118,"marketStatus":"Market Closed","change":0.0134,"latestTime":"04-25 16:00:00 EDT","open":0.3002,"high":0.3167,"low":0.288,"amount":122403.38665824001,"amplitude":0.096763,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-3.304118,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1745827200000},"marketStatusCode":7,"adr":0,"listingDate":1661918400000,"exchange":"NASDAQ","adjPreClose":0.2966,"preHourTrading":{"tag":"盘前","latestPrice":0.3001,"preClose":0.2966,"latestTime":"09:27 EDT","volume":8686,"amount":2651.07733848,"timestamp":1745587661676},"postHourTrading":{"tag":"盘后","latestPrice":0.31,"preClose":0.31,"latestTime":"19:46 EDT","volume":26404,"amount":7950.7017,"timestamp":1745624777585},"volumeRatio":0.1781929046008203},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SHPH\",,,,,undefined,":{"symbol":"SHPH","floatShares":5554536,"roa":"-113.74%","roe":"-383.84%","lyrEps":-3.186207,"volumeRatio":0.1781929046008203,"shares":6257693,"dividePrice":0,"high":0.3167,"amplitude":0.096763,"preClose":0.2966,"low":0.288,"week52Low":0.23,"pbRate":"2.74","week52High":4.7104,"institutionHeld":0,"latestPrice":0.31,"eps":-3.304118,"divideRate":0,"volume":404784,"delay":0,"ttmEps":-3.304118,"open":0.3002,"prevYearClose":0.859,"prevWeekClose":0.2535,"prevMonthClose":0.389,"prevQuarterClose":0.389,"fiveDayClose":0.2535,"twentyDayClose":0.3949,"sixtyDayClose":0.751},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SHPH\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2486006171","title":"Shuttle first patient enrollment, dosing in Phase 2 Ropidoxuridine line","url":"https://stock-news.laohu8.com/highlight/detail?id=2486006171","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486006171?lang=en_us&edition=fundamental","pubTime":"2024-11-26 22:06","pubTimestamp":1732629970,"startTime":"0","endTime":"0","summary":"Shuttle Pharmaceuticals (SHPH) announced first patient enrollment and dosing at the UVA Cancer Center in its Phase 2 Clinical Trial of Ropidoxuridi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/shuttle-first-patient-enrollment-dosing-in-phase-2-ropidoxuridine-line?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/shuttle-first-patient-enrollment-dosing-in-phase-2-ropidoxuridine-line?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","SHPH"],"gpt_icon":0},{"id":"2486685005","title":"BRIEF-Shuttle Pharma Expands Patient Enrollment For Phase 2 Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2486685005","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486685005?lang=en_us&edition=fundamental","pubTime":"2024-11-26 22:01","pubTimestamp":1732629697,"startTime":"0","endTime":"0","summary":"BRIEF-Shuttle Pharma Expands Patient Enrollment For Phase 2 Clinical TrialNov 26 (Reuters) - Shuttle Pharmaceuticals Holdings Inc SHPH.O:SHUTTLE PHARMA EXPANDS PATIENT ENROLLMENT FOR PHASE 2 CLINICAL ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241126:nTUA7DHNMZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SHPH","BK4139"],"gpt_icon":0},{"id":"2486005559","title":"Shuttle Pharma Expands Patient Enrollment for Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients With Glioblastoma as Uva Cancer Center Doses Its First Patient","url":"https://stock-news.laohu8.com/highlight/detail?id=2486005559","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486005559?lang=en_us&edition=fundamental","pubTime":"2024-11-26 22:00","pubTimestamp":1732629602,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241126:nTUA7DHNMZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","SHPH"],"gpt_icon":0},{"id":"2486057420","title":"Shuttle Pharma Expands Patient Enrollment for Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma as UVA Cancer Center Doses Its First Patient","url":"https://stock-news.laohu8.com/highlight/detail?id=2486057420","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486057420?lang=en_us&edition=fundamental","pubTime":"2024-11-26 22:00","pubTimestamp":1732629600,"startTime":"0","endTime":"0","summary":"GAITHERSBURG, Md., Nov. 26, 2024  -- Shuttle Pharmaceuticals Holdings, Inc.  , a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer patients treated with radiation therapy , announced today first patient enrollment and dosing at the UVA Cancer Center in its Phase 2 Clinical Trial of Ropidoxuridine for the treatment of patients with glioblastoma. UVA is one of six cancer centers conducting the clinical trials. Shuttle Pharma previously announced the dosing of patients at Miami Cancer Institute, part of Baptist Health South Florida.In addition to UVA Cancer Center, the Phase 2 trial is currently being conducted at Georgetown University Medical Center, John Theurer Cancer Center at Hackensack University Medical Center, Allegheny Health Network  Cancer Institute, and Miami Cancer Institute, part of Baptist Health South Florida.An estimated 800,000 patients in the US are treated with radiation therapy for their cancers yearly. According","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/bsZFl8YAjLNtWtfWVxgmQA--~B/aD00NDQ7dz02NDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/6069b9284cf78aa5773f84bd4df49949","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/bsZFl8YAjLNtWtfWVxgmQA--~B/aD00NDQ7dz02NDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/6069b9284cf78aa5773f84bd4df49949"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/shuttle-pharma-expands-patient-enrollment-140000835.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SHPH","BK4139"],"gpt_icon":0},{"id":"2483866551","title":"Shuttle Pharmaceuticals Q3 EPS $(1.59) Down From $(0.91) YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2483866551","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483866551?lang=en_us&edition=fundamental","pubTime":"2024-11-14 06:10","pubTimestamp":1731535816,"startTime":"0","endTime":"0","summary":"Shuttle Pharmaceuticals (NASDAQ:SHPH) reported quarterly losses of $(1.59) per share. This is a 74.73 percent decrease over losses of $(0.91) per share from the same period last year.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/11/41957320/shuttle-pharmaceuticals-q3-eps-1-59-down-from-0-91-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Shuttle Pharmaceuticals Q3 EPS $(1.59) Down From $(0.91) YoY","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SHPH"],"gpt_icon":0},{"id":"2483486527","title":"Shuttle Pharma Provides Third Quarter 2024 Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2483486527","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483486527?lang=en_us&edition=fundamental","pubTime":"2024-11-14 06:00","pubTimestamp":1731535221,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241113:nTUA3CVTFC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","SHPH"],"gpt_icon":0},{"id":"2483663948","title":"Shuttle Pharma Provides Third Quarter 2024 Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2483663948","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483663948?lang=en_us&edition=fundamental","pubTime":"2024-11-14 06:00","pubTimestamp":1731535200,"startTime":"0","endTime":"0","summary":"GAITHERSBURG, Md., Nov. 13, 2024  -- Shuttle Pharmaceuticals Holdings, Inc.  , a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer patients treated with radiation therapy , today provided a corporate update in connection with the filing of its Quarterly Report on Form 10-Q for the third quarter ended September 30, 2024.Shuttle Pharma’s recent highlights include the following:. “We made tremendous progress over the past few months to advance our Phase 2 clinical trial of Ropidoxuridine for the treatment of patients with glioblastoma, with the first three patients dosed in October 2024,” stated Shuttle Pharma’s Chairman and CEO, Anatoly Dritschilo, M.D. “The initial patient dosing followed the successful engagement of all six of the planned clinical trial site locations, each of which are nationally recognized cancer centers that are most likely to treat IDH wild-type, methylation negative glioblastoma patients – the target of the c","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/bsZFl8YAjLNtWtfWVxgmQA--~B/aD00NDQ7dz02NDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/6069b9284cf78aa5773f84bd4df49949","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/bsZFl8YAjLNtWtfWVxgmQA--~B/aD00NDQ7dz02NDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/6069b9284cf78aa5773f84bd4df49949"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/shuttle-pharma-provides-third-quarter-220000759.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","SHPH"],"gpt_icon":0},{"id":"2479229711","title":"Shuttle Pharmaceuticals Prices $4.5 Million Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2479229711","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479229711?lang=en_us&edition=fundamental","pubTime":"2024-10-30 16:21","pubTimestamp":1730276478,"startTime":"0","endTime":"0","summary":"Shuttle Pharmaceuticals  said late Tuesday it has priced its public offering of up to about 3 million shares and warrants to purchase an additional 3 million shares at a combined price of $1.525 per share and accompanying warrant.Gross proceeds from the offering are estimated to be about $4.5 million.The warrants will have an exercise price of $1.40 per share, are immediately exercisable and expire five years after issuance.Proceeds from the offering, which are expected to close around Thursday, will be used to fund trials of its product candidates, including $2.3 million owed to Theradex Systems for support in phase 2 trials of radiation sensitizer Ropidoxuridine, as well as for general corporate purposes.Price: 1.7300, Change: -0.07, Percent Change: -3.89","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SHPH","BK4139"],"gpt_icon":0},{"id":"2479229898","title":"Shuttle Pharmaceuticals dips 6%, prices $4.5M share offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2479229898","media":"seekingalpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479229898?lang=en_us&edition=fundamental","pubTime":"2024-10-30 14:01","pubTimestamp":1730268072,"startTime":"0","endTime":"0","summary":"Shuttle Pharmaceuticals  priced a public offering with a health-care focused institutional investor for the purchase and sale of up to ~2.95M shares and warrants to purchase up to ~2.95M shares at a combined offering price of $1.525 per share and accompanying warrant.  The aggregate gross proceeds of approximately $4.5M and assuming no exercise of the warrants. The warrants will have an exercise price of $1.40 per share. The closing of the offering is expected to occur on or about October 31, 2024. Net proceeds will be used to fund IND-enabling and Phase I and II clinical trials of product candidates, including $2.3M in payments that will be owed to Theradex Systems. The stock price dropped 5.6% on Tuesday during after hours of trading.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4221917-shuttle-pharmaceuticals-dips-6-prices-35m-share-offering","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha_trending_news","symbols":["BK4139","SHPH"],"gpt_icon":0},{"id":"2479299460","title":"BRIEF-Shuttle Pharmaceuticals Holdings Announces Pricing Of $4.5 Mln Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2479299460","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479299460?lang=en_us&edition=fundamental","pubTime":"2024-10-30 09:15","pubTimestamp":1730250931,"startTime":"0","endTime":"0","summary":"Oct 29  - Shuttle Pharmaceuticals Holdings Inc :   * SHUTTLE PHARMACEUTICALS HOLDINGS, INC. ANNOUNCES PRICING OF $4.5 MILLION PUBLIC OFFERING PRICED AT-THE-MARKET UNDER NASDAQ RULES   * SHUTTLE PHARMACEUTICALS HOLDINGS INC -  PRICES PUBLIC OFFERING OF UP TO 2.9 MILLION SHARES OF COMMON STOCK AND WARRANTS AT$1.525 PER SHARESource text:    Further company coverage:    ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NQmain",".IXIC","MNQmain","TQQQ","BK4139","SHPH","SQQQ","QLD","QID","PSQ"],"gpt_icon":1},{"id":"2479299312","title":"Shuttle Pharmaceuticals prices $4.5M at-the-market offering at $1.525 per share","url":"https://stock-news.laohu8.com/highlight/detail?id=2479299312","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479299312?lang=en_us&edition=fundamental","pubTime":"2024-10-30 09:10","pubTimestamp":1730250610,"startTime":"0","endTime":"0","summary":"Shuttle Pharmaceuticals (SHPH) announced the pricing of its “reasonable best efforts” public offering with a health-care focused institutional inve...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/shuttle-pharmaceuticals-prices-4-5m-at-the-market-offering-at-1-525-per-share?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/shuttle-pharmaceuticals-prices-4-5m-at-the-market-offering-at-1-525-per-share?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SHPH","BK4139"],"gpt_icon":0},{"id":"2479967092","title":"Shuttle Pharmaceuticals Holdings, Inc. Announces Pricing of $4.5 Million Public Offering Priced at-the-Market Under Nasdaq Rules","url":"https://stock-news.laohu8.com/highlight/detail?id=2479967092","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479967092?lang=en_us&edition=fundamental","pubTime":"2024-10-30 09:05","pubTimestamp":1730250352,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241030:nTUA1YHRFZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SHPH","BK4139"],"gpt_icon":0},{"id":"2479299621","title":"Shuttle Pharmaceuticals Holdings Inc -  Prices Public Offering of up to 2.9 Mln Shares of Common Stock and Warrants at$1.525 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2479299621","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479299621?lang=en_us&edition=fundamental","pubTime":"2024-10-30 09:05","pubTimestamp":1730250352,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241030:nTUA1YHRFZ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SHPH","BK4139"],"gpt_icon":0},{"id":"2479829606","title":"Shuttle Pharmaceuticals Holdings, Inc. Announces Pricing of $4.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules","url":"https://stock-news.laohu8.com/highlight/detail?id=2479829606","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479829606?lang=en_us&edition=fundamental","pubTime":"2024-10-30 09:05","pubTimestamp":1730250300,"startTime":"0","endTime":"0","summary":"GAITHERSBURG, Md., Oct. 29, 2024  -- Shuttle Pharmaceuticals Holdings, Inc.  , a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer patients treated with radiation therapy , today announced the pricing of its \"reasonable best efforts\" public offering with a health-care focused institutional investor for the purchase and sale of up to 2,950,820 shares of common stock  and warrants to purchase up to 2,950,820 shares of common stock at a combined offering price of $1.525 per share and accompanying warrant, priced at-the-market under Nasdaq rules . The Company expects to receive aggregate gross proceeds of approximately $4.5 million, before deducting placement agent fees and other offering expenses, and assuming no exercise of the warrants. The warrants will have an exercise price of $1.40 per share, will be exercisable immediately and will expire five years from the issuance date.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/bsZFl8YAjLNtWtfWVxgmQA--~B/aD00NDQ7dz02NDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/6069b9284cf78aa5773f84bd4df49949","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/bsZFl8YAjLNtWtfWVxgmQA--~B/aD00NDQ7dz02NDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/6069b9284cf78aa5773f84bd4df49949"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/shuttle-pharmaceuticals-holdings-inc-announces-010500103.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PSQ","TQQQ","BK4112","QID","IE00BKPKM429.USD","IE00B3QW5Z07.USD","SQQQ","MNQmain","SHPH","BK4588",".IXIC","LU2095319765.USD","BK4585","QLD","IE00BGHQF748.EUR","IE00B64PRP62.GBP","BK4139","LU2210150020.SGD","LU2210149790.SGD","NDAQ","NQmain"],"gpt_icon":1},{"id":"2479252460","title":"Shuttle Pharma Pays off Senior Secured Convertible Note","url":"https://stock-news.laohu8.com/highlight/detail?id=2479252460","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479252460?lang=en_us&edition=fundamental","pubTime":"2024-10-30 04:39","pubTimestamp":1730234366,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241029:nFWN3M51J0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SHPH","BK4139"],"gpt_icon":0},{"id":"2479259050","title":"Shuttle Pharma Pays Off Senior Secured Convertible Note","url":"https://stock-news.laohu8.com/highlight/detail?id=2479259050","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479259050?lang=en_us&edition=fundamental","pubTime":"2024-10-30 04:05","pubTimestamp":1730232300,"startTime":"0","endTime":"0","summary":"GAITHERSBURG, Md., Oct. 29, 2024  -- Shuttle Pharmaceuticals Holdings, Inc.  , a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer patients treated with radiation therapy , today announced that, during the third quarter of this year, it paid off the entirety of the outstanding balance due under its Senior Secured Convertible Note  issued on January 11, 2023.The initial balance of the Note was $4.3 million and was originally repayable over a 26-month period ending March 11, 2025. During the term of the note, Shuttle Pharma made periodic cash payments totaling $1.3 million and equity issuances totaling 1,094,970 shares . As a result, the Company now has a total of 2,946,099 shares outstanding. Additionally, in October 2024, Shuttle Pharma closed on a convertible note and warrant offering, receiving a total of $790,000 in gross proceeds, including $237,500 invested by the Company’s Chief Executive Officer, Dr. Anatoly Dritschilo.An e","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/bsZFl8YAjLNtWtfWVxgmQA--~B/aD00NDQ7dz02NDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/6069b9284cf78aa5773f84bd4df49949","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/bsZFl8YAjLNtWtfWVxgmQA--~B/aD00NDQ7dz02NDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/6069b9284cf78aa5773f84bd4df49949"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/shuttle-pharma-pays-off-senior-200500685.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","SHPH"],"gpt_icon":0},{"id":"2479289221","title":"US Stocks Mixed; McDonald's Posts Upbeat Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2479289221","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479289221?lang=en_us&edition=fundamental","pubTime":"2024-10-29 22:30","pubTimestamp":1730212248,"startTime":"0","endTime":"0","summary":" ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/10/41601556/us-stocks-mixed-mcdonalds-posts-upbeat-earnings","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HRYU","MCD","EFSH","PGHL","BKYI","GLYC","SHPH"],"gpt_icon":1},{"id":"2479407159","title":"Shuttle Pharmaceuticals doses first patients in Phase 2 trial of Ropidoxuridine","url":"https://stock-news.laohu8.com/highlight/detail?id=2479407159","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479407159?lang=en_us&edition=fundamental","pubTime":"2024-10-29 21:05","pubTimestamp":1730207145,"startTime":"0","endTime":"0","summary":"Shuttle Pharmaceuticals (SHPH) announced that the first three patients in its Phase 2 Clinical Trial of Ropidoxuridine for the treatment of patient...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/shuttle-pharmaceuticals-doses-first-patients-in-phase-2-trial-of-ropidoxuridine?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/shuttle-pharmaceuticals-doses-first-patients-in-phase-2-trial-of-ropidoxuridine?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SHPH","BK4139"],"gpt_icon":0},{"id":"2479021854","title":"Shuttle Pharma Doses First Patients in Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients With Glioblastoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2479021854","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479021854?lang=en_us&edition=fundamental","pubTime":"2024-10-29 21:00","pubTimestamp":1730206802,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241029:nTUA3FWYGJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","SHPH"],"gpt_icon":0},{"id":"2479347564","title":"Shuttle Pharmaceuticals Soars Premarket Following Completion of Phase 2 Glioblastoma Trial Site Enrollment","url":"https://stock-news.laohu8.com/highlight/detail?id=2479347564","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479347564?lang=en_us&edition=fundamental","pubTime":"2024-10-29 17:56","pubTimestamp":1730195795,"startTime":"0","endTime":"0","summary":"Price: 2.1806, Change: +0.85, Percent Change: +63.95","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SHPH","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":47,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SHPH\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-08-13","symbol":"SHPH","defaultRemindTime":1723555800000,"type":"split","dateTimestamp":1723521600000,"forFactor":8,"toFactor":1,"ratio":8}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SHPH\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SHPH\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SHPH\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SHPH","date":"2025-04-25","current":-0.20296,"percent":0.986777,"low":-282.45653,"twenty":-8.291085,"median":-1.29342,"eighty":-0.368296,"high":-0.17162,"avg":-7.848262,"sd":28.083216,"marketCap":1856031},"quantilePoints":[{"date":"2022-09-02","current":-80.316838,"twenty":-252.442828,"median":-207.422276,"eighty":-131.159013,"marketCap":157029297},{"date":"2022-09-09","current":-233.475315,"twenty":-230.586961,"median":-207.422276,"eighty":-174.21591,"marketCap":456472959},{"date":"2022-09-16","current":-54.096471,"twenty":-240.214809,"median":-213.22791,"eighty":-114.354765,"marketCap":105765255},{"date":"2022-09-23","current":-35.140877,"twenty":-231.91079,"median":-171.496043,"eighty":-51.64137,"marketCap":68704737},{"date":"2022-09-30","current":-28.051587,"twenty":-224.32886,"median":-68.891528,"eighty":-35.593125,"marketCap":54844303},{"date":"2022-10-07","current":-23.162421,"twenty":-216.71129,"median":-51.027595,"eighty":-28.467166,"marketCap":45285383},{"date":"2022-10-14","current":-21.023412,"twenty":-202.956897,"median":-37.836406,"eighty":-23.309096,"marketCap":41103356},{"date":"2022-10-21","current":-16.134246,"twenty":-182.375512,"median":-34.346388,"eighty":-19.764451,"marketCap":31544436},{"date":"2022-10-28","current":-17.173194,"twenty":-157.210724,"median":-29.090535,"eighty":-18.701058,"marketCap":33575706},{"date":"2022-11-04","current":-12.03957,"twenty":-96.118924,"median":-24.201369,"eighty":-16.170915,"marketCap":23538840},{"date":"2022-11-11","current":-11.428424,"twenty":-75.746714,"median":-23.009635,"eighty":-15.963125,"marketCap":22343975},{"date":"2022-11-18","current":-8.688263,"twenty":-56.792269,"median":-20.106693,"eighty":-13.665217,"marketCap":23776187},{"date":"2022-11-25","current":-8.092496,"twenty":-54.096471,"median":-19.678891,"eighty":-11.428424,"marketCap":22145820},{"date":"2022-12-02","current":-11.964979,"twenty":-51.027595,"median":-18.976073,"eighty":-10.511706,"marketCap":32743207},{"date":"2022-12-09","current":-13.65646,"twenty":-38.807751,"median":-16.928735,"eighty":-10.773446,"marketCap":37372091},{"date":"2022-12-16","current":-11.890509,"twenty":-38.270696,"median":-16.103689,"eighty":-10.817279,"marketCap":32539411},{"date":"2022-12-23","current":-10.425916,"twenty":-37.402116,"median":-16.012017,"eighty":-10.773446,"marketCap":28531425},{"date":"2022-12-30","current":-9.730855,"twenty":-35.593125,"median":-15.706444,"eighty":-10.207468,"marketCap":26629330},{"date":"2023-01-06","current":-8.688263,"twenty":-34.664184,"median":-14.85084,"eighty":-9.581913,"marketCap":23776187},{"date":"2023-01-13","current":-11.617449,"twenty":-34.126376,"median":-14.028433,"eighty":-9.045723,"marketCap":31792159},{"date":"2023-01-20","current":-10.823093,"twenty":-32.439613,"median":-13.611947,"eighty":-9.224453,"marketCap":29618336},{"date":"2023-01-27","current":-10.227327,"twenty":-29.298324,"median":-13.355101,"eighty":-9.432971,"marketCap":27987969},{"date":"2023-02-03","current":-10.0908,"twenty":-26.780404,"median":-12.151216,"eighty":-9.432971,"marketCap":27614351},{"date":"2023-02-10","current":-9.693133,"twenty":-24.604725,"median":-12.014627,"eighty":-9.532265,"marketCap":26526101},{"date":"2023-02-17","current":-9.494299,"twenty":-24.07914,"median":-11.753979,"eighty":-9.457502,"marketCap":25981976},{"date":"2023-02-24","current":-8.450423,"twenty":-23.749121,"median":-11.617449,"eighty":-9.322967,"marketCap":23125319},{"date":"2023-03-03","current":-8.84809,"twenty":-23.101307,"median":-11.428424,"eighty":-9.246599,"marketCap":24213569},{"date":"2023-03-10","current":-6.859756,"twenty":-22.490162,"median":-11.195448,"eighty":-8.986146,"marketCap":18772318},{"date":"2023-03-17","current":-6.537502,"twenty":-20.840068,"median":-10.823093,"eighty":-8.858032,"marketCap":19798484},{"date":"2023-03-24","current":-5.680864,"twenty":-20.021133,"median":-10.795362,"eighty":-8.688263,"marketCap":17204200},{"date":"2023-03-31","current":-5.996467,"twenty":-19.678891,"median":-10.723799,"eighty":-8.54925,"marketCap":18159988},{"date":"2023-04-06","current":-6.537502,"twenty":-19.678891,"median":-10.425916,"eighty":-8.450423,"marketCap":19798484},{"date":"2023-04-14","current":-6.041553,"twenty":-19.556662,"median":-10.258449,"eighty":-8.152173,"marketCap":18296530},{"date":"2023-04-21","current":-6.31207,"twenty":-19.434433,"median":-10.227327,"eighty":-7.447082,"marketCap":19115777},{"date":"2023-04-28","current":-7.303967,"twenty":-18.517714,"median":-10.084592,"eighty":-7.248493,"marketCap":22119685},{"date":"2023-05-05","current":-6.086639,"twenty":-17.173194,"median":-10.041091,"eighty":-6.988364,"marketCap":18433071},{"date":"2023-05-12","current":-5.094743,"twenty":-16.977627,"median":-9.929444,"eighty":-6.582588,"marketCap":15429163},{"date":"2023-05-18","current":-4.914398,"twenty":-16.562048,"median":-9.730855,"eighty":-6.465364,"marketCap":14882998},{"date":"2023-05-25","current":-5.861208,"twenty":-16.244252,"median":-9.693133,"eighty":-6.31207,"marketCap":17750365},{"date":"2023-06-02","current":-4.613085,"twenty":-16.122023,"median":-9.544008,"eighty":-6.266984,"marketCap":15323313},{"date":"2023-06-09","current":-4.894734,"twenty":-16.085354,"median":-9.463635,"eighty":-6.172303,"marketCap":16258867},{"date":"2023-06-15","current":-4.627749,"twenty":-16.060908,"median":-9.432971,"eighty":-6.136235,"marketCap":15372020},{"date":"2023-06-23","current":-4.983729,"twenty":-16.02424,"median":-9.345174,"eighty":-6.086639,"marketCap":16554483},{"date":"2023-06-30","current":-5.072724,"twenty":-16.012017,"median":-9.295466,"eighty":-5.996467,"marketCap":16850099},{"date":"2023-07-07","current":-4.895179,"twenty":-15.999794,"median":-9.264924,"eighty":-5.996467,"marketCap":16260345},{"date":"2023-07-14","current":-4.583251,"twenty":-15.950902,"median":-9.066183,"eighty":-5.861659,"marketCap":15224212},{"date":"2023-07-21","current":-4.449758,"twenty":-15.853119,"median":-9.016535,"eighty":-5.861208,"marketCap":14780789},{"date":"2023-07-27","current":-4.000778,"twenty":-15.755336,"median":-8.986146,"eighty":-5.838665,"marketCap":13289407},{"date":"2023-08-03","current":-4.005227,"twenty":-15.543988,"median":-8.961322,"eighty":-5.69439,"marketCap":13304188},{"date":"2023-08-11","current":-3.629668,"twenty":-14.8855,"median":-8.897799,"eighty":-5.635777,"marketCap":12056689},{"date":"2023-08-18","current":-2.349846,"twenty":-14.799928,"median":-8.768116,"eighty":-5.251943,"marketCap":11534927},{"date":"2023-08-25","current":-2.292603,"twenty":-14.488296,"median":-8.688263,"eighty":-5.069521,"marketCap":11253932},{"date":"2023-09-01","current":-2.371448,"twenty":-14.045184,"median":-8.613792,"eighty":-4.919365,"marketCap":11640968},{"date":"2023-09-08","current":-2.163437,"twenty":-14.000515,"median":-8.514755,"eighty":-4.894289,"marketCap":10619886},{"date":"2023-09-15","current":-2.17145,"twenty":-13.65646,"median":-8.450423,"eighty":-4.761241,"marketCap":10659219},{"date":"2023-09-20","current":-2.132028,"twenty":-13.62085,"median":-8.291085,"eighty":-4.690223,"marketCap":10465701},{"date":"2023-09-28","current":-1.778826,"twenty":-13.585239,"median":-8.291085,"eighty":-4.666573,"marketCap":8731906},{"date":"2023-10-03","current":-1.849979,"twenty":-13.544826,"median":-8.201881,"eighty":-4.64388,"marketCap":9081182},{"date":"2023-10-13","current":-2.036836,"twenty":-13.499611,"median":-8.152173,"eighty":-4.627749,"marketCap":9998426},{"date":"2023-10-19","current":-1.891005,"twenty":-13.434537,"median":-8.022918,"eighty":-4.613667,"marketCap":9282567},{"date":"2023-10-27","current":-1.602059,"twenty":-13.394819,"median":-7.799506,"eighty":-4.565452,"marketCap":7864189},{"date":"2023-11-03","current":-1.628108,"twenty":-12.967853,"median":-7.447082,"eighty":-4.46048,"marketCap":7992062},{"date":"2023-11-10","current":-1.627783,"twenty":-12.441592,"median":-7.330403,"eighty":-4.003447,"marketCap":7990464},{"date":"2023-11-17","current":-1.441985,"twenty":-12.128887,"median":-7.198846,"eighty":-3.713768,"marketCap":8223832},{"date":"2023-11-24","current":-1.430714,"twenty":-12.03957,"median":-6.988364,"eighty":-3.02365,"marketCap":8159553},{"date":"2023-12-01","current":-1.402381,"twenty":-12.029593,"median":-6.833887,"eighty":-2.449276,"marketCap":7997962},{"date":"2023-12-08","current":-1.402661,"twenty":-11.994768,"median":-6.582588,"eighty":-2.374562,"marketCap":7999562},{"date":"2023-12-15","current":-1.374608,"twenty":-11.935191,"median":-6.44733,"eighty":-2.344923,"marketCap":7839571},{"date":"2023-12-22","current":-1.346274,"twenty":-11.781285,"median":-6.31207,"eighty":-2.270039,"marketCap":7677980},{"date":"2023-12-29","current":-1.290729,"twenty":-11.617449,"median":-6.266984,"eighty":-2.243565,"marketCap":7361197},{"date":"2024-01-05","current":-1.51291,"twenty":-11.617449,"median":-6.266984,"eighty":-2.236193,"marketCap":8628328},{"date":"2024-01-12","current":-1.297181,"twenty":-11.617449,"median":-6.165541,"eighty":-2.093951,"marketCap":7397995},{"date":"2024-01-19","current":-1.24921,"twenty":-11.577731,"median":-6.131726,"eighty":-1.955106,"marketCap":7124410},{"date":"2024-01-26","current":-1.151585,"twenty":-11.482262,"median":-6.086639,"eighty":-1.86556,"marketCap":6567640},{"date":"2024-02-02","current":-1.094076,"twenty":-11.428424,"median":-5.996467,"eighty":-1.665229,"marketCap":6239658},{"date":"2024-02-09","current":-1.06462,"twenty":-11.345163,"median":-5.996467,"eighty":-1.626611,"marketCap":6071667},{"date":"2024-02-16","current":-1.034916,"twenty":-11.200412,"median":-5.90652,"eighty":-1.580177,"marketCap":5902261},{"date":"2024-02-23","current":-1.011811,"twenty":-11.153493,"median":-5.861208,"eighty":-1.532376,"marketCap":5770492},{"date":"2024-03-01","current":-1.103102,"twenty":-11.032592,"median":-5.748493,"eighty":-1.447546,"marketCap":6291138},{"date":"2024-03-08","current":-1.155229,"twenty":-10.823093,"median":-5.680864,"eighty":-1.428518,"marketCap":6588421},{"date":"2024-03-15","current":-1.225106,"twenty":-10.82193,"median":-5.635777,"eighty":-1.403856,"marketCap":6986940},{"date":"2024-03-22","current":-1.273569,"twenty":-10.808512,"median":-5.361959,"eighty":-1.402379,"marketCap":7263332},{"date":"2024-03-28","current":-1.069946,"twenty":-10.773446,"median":-5.184915,"eighty":-1.388635,"marketCap":7053855},{"date":"2024-04-05","current":-1.089052,"twenty":-10.737009,"median":-5.072724,"eighty":-1.374608,"marketCap":7179816},{"date":"2024-04-12","current":-1.07504,"twenty":-10.723799,"median":-4.985424,"eighty":-1.348238,"marketCap":7087444},{"date":"2024-04-19","current":-1.022562,"twenty":-10.511706,"median":-4.914398,"eighty":-1.337967,"marketCap":6741470},{"date":"2024-04-26","current":-1.016958,"twenty":-10.425916,"median":-4.894512,"eighty":-1.303718,"marketCap":6704521},{"date":"2024-05-03","current":-1.120895,"twenty":-10.376268,"median":-4.805739,"eighty":-1.287924,"marketCap":7389752},{"date":"2024-05-10","current":-1.077012,"twenty":-10.276974,"median":-4.739215,"eighty":-1.273569,"marketCap":7100444},{"date":"2024-05-17","current":-0.942057,"twenty":-10.239925,"median":-4.672246,"eighty":-1.237147,"marketCap":6922854},{"date":"2024-05-24","current":-0.97619,"twenty":-10.227327,"median":-4.635815,"eighty":-1.195521,"marketCap":7173684},{"date":"2024-05-31","current":-1.215374,"twenty":-10.227327,"median":-4.621871,"eighty":-1.189992,"marketCap":8931363},{"date":"2024-06-07","current":-1.065455,"twenty":-10.197638,"median":-4.583251,"eighty":-1.186002,"marketCap":7829660},{"date":"2024-06-14","current":-1.005487,"twenty":-10.130566,"median":-4.529967,"eighty":-1.177893,"marketCap":7388978},{"date":"2024-06-21","current":-0.923318,"twenty":-10.085834,"median":-4.467628,"eighty":-1.159877,"marketCap":6785144},{"date":"2024-06-28","current":-0.869759,"twenty":-10.080868,"median":-4.449758,"eighty":-1.149523,"marketCap":6391559},{"date":"2024-07-05","current":-0.881203,"twenty":-10.078385,"median":-4.027031,"eighty":-1.124633,"marketCap":6475658},{"date":"2024-07-12","current":-0.963372,"twenty":-10.056009,"median":-3.908223,"eighty":-1.110142,"marketCap":7079492},{"date":"2024-07-15","current":-0.971154,"twenty":-10.04855,"median":-3.815668,"eighty":-1.102764,"marketCap":7136680},{"date":"2024-08-02","current":-0.845955,"twenty":-10.041091,"median":-3.798091,"eighty":-1.101412,"marketCap":6216632},{"date":"2024-08-09","current":-0.792396,"twenty":-9.991383,"median":-3.677725,"eighty":-1.09542,"marketCap":5823046},{"date":"2024-08-16","current":-0.597959,"twenty":-9.941832,"median":-3.629668,"eighty":-1.093784,"marketCap":4394195},{"date":"2024-08-23","current":-0.612264,"twenty":-9.899462,"median":-2.514716,"eighty":-1.087676,"marketCap":4499320},{"date":"2024-08-30","current":-0.527863,"twenty":-9.763077,"median":-2.43587,"eighty":-1.075611,"marketCap":3879086},{"date":"2024-09-06","current":-0.634062,"twenty":-9.708222,"median":-2.411832,"eighty":-1.07244,"marketCap":4562394},{"date":"2024-09-13","current":-0.495187,"twenty":-9.693133,"median":-2.371769,"eighty":-1.0701,"marketCap":3563121},{"date":"2024-09-20","current":-0.501377,"twenty":-9.685977,"median":-2.349846,"eighty":-1.065245,"marketCap":3607660},{"date":"2024-09-27","current":-0.417814,"twenty":-9.598888,"median":-2.30943,"eighty":-1.058966,"marketCap":3006383},{"date":"2024-10-04","current":-0.363653,"twenty":-9.514183,"median":-2.259911,"eighty":-1.037615,"marketCap":2616667},{"date":"2024-10-11","current":-0.343536,"twenty":-9.457502,"median":-2.243565,"eighty":-1.032141,"marketCap":2471915},{"date":"2024-10-18","current":-0.374485,"twenty":-9.432971,"median":-2.227539,"eighty":-1.018181,"marketCap":2694610},{"date":"2024-10-25","current":-0.397697,"twenty":-9.380293,"median":-2.147733,"eighty":-1.014539,"marketCap":2861632},{"date":"2024-10-31","current":-0.557086,"twenty":-9.325291,"median":-2.011996,"eighty":-1.00644,"marketCap":4008511},{"date":"2024-11-08","current":-0.362106,"twenty":-9.295466,"median":-1.955106,"eighty":-0.990068,"marketCap":2605532},{"date":"2024-11-15","current":-0.259375,"twenty":-9.295466,"median":-1.889968,"eighty":-0.98435,"marketCap":2382837},{"date":"2024-11-22","current":-0.213803,"twenty":-9.271032,"median":-1.778826,"eighty":-0.973168,"marketCap":1964170},{"date":"2024-11-29","current":-0.338294,"twenty":-9.204594,"median":-1.672067,"eighty":-0.960397,"marketCap":3107851},{"date":"2024-12-06","current":-0.318427,"twenty":-9.077738,"median":-1.628434,"eighty":-0.946292,"marketCap":2925338},{"date":"2024-12-13","current":-0.279252,"twenty":-9.034768,"median":-1.625829,"eighty":-0.917092,"marketCap":2565443},{"date":"2024-12-20","current":-0.271274,"twenty":-8.986146,"median":-1.602059,"eighty":-0.914507,"marketCap":2492144},{"date":"2024-12-27","current":-0.317749,"twenty":-8.986146,"median":-1.564286,"eighty":-0.890244,"marketCap":2919107},{"date":"2025-01-03","current":-0.339491,"twenty":-8.946428,"median":-1.540191,"eighty":-0.870125,"marketCap":3118846},{"date":"2025-01-10","current":-0.342722,"twenty":-8.936499,"median":-1.499865,"eighty":-0.842888,"marketCap":3148531},{"date":"2025-01-17","current":-0.351339,"twenty":-8.913279,"median":-1.444741,"eighty":-0.769782,"marketCap":3227694},{"date":"2025-01-24","current":-0.367017,"twenty":-8.877915,"median":-1.430714,"eighty":-0.667768,"marketCap":3371725},{"date":"2025-01-31","current":-0.313321,"twenty":-8.823877,"median":-1.422327,"eighty":-0.613408,"marketCap":2878427},{"date":"2025-02-07","current":-0.273269,"twenty":-8.772004,"median":-1.407512,"eighty":-0.576788,"marketCap":2510473},{"date":"2025-02-14","current":-0.275662,"twenty":-8.72451,"median":-1.402661,"eighty":-0.558558,"marketCap":2532459},{"date":"2025-02-21","current":-0.237364,"twenty":-8.688263,"median":-1.402379,"eighty":-0.538449,"marketCap":2180626},{"date":"2025-02-28","current":-0.24583,"twenty":-8.688263,"median":-1.397051,"eighty":-0.521185,"marketCap":2248061},{"date":"2025-03-07","current":-0.245179,"twenty":-8.678334,"median":-1.384324,"eighty":-0.496425,"marketCap":2242111},{"date":"2025-03-14","current":-0.292876,"twenty":-8.628686,"median":-1.374608,"eighty":-0.449382,"marketCap":2678292},{"date":"2025-03-21","current":-0.277548,"twenty":-8.579039,"median":-1.36535,"eighty":-0.421528,"marketCap":2538120},{"date":"2025-03-28","current":-0.270226,"twenty":-8.529495,"median":-1.347116,"eighty":-0.412862,"marketCap":2471162},{"date":"2025-04-04","current":-0.273853,"twenty":-8.490087,"median":-1.339596,"eighty":-0.403578,"marketCap":2504328},{"date":"2025-04-11","current":-0.28398,"twenty":-8.481824,"median":-1.316257,"eighty":-0.387762,"marketCap":2596942},{"date":"2025-04-17","current":-0.175178,"twenty":-8.450423,"median":-1.303718,"eighty":-0.374485,"marketCap":1601969},{"date":"2025-04-25","current":-0.20296,"twenty":-8.291085,"median":-1.29342,"eighty":-0.368296,"marketCap":1856031}],"updateTime":1745784644228}}}